Clinical Trials on Hepatocarcinoma

Total 18 results

Hospital Donostia
INSTITUTO BIODONOSTIA

Completed

Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced Hepatocarcinoma (ESTAHEP-2010)

Advanced Hepatocarcinoma

Spain
Istituto Clinico Humanitas

Completed

11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE

Hepatocarcinoma

Italy
Istituto Clinico Humanitas

Recruiting

Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma (Immunocabo)

Hepatocarcinoma

Italy
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib (HELP)

Hepatocarcinoma

France
IHU Strasbourg

Completed

Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas (3D-HAPPI)

Hepatocarcinoma

France
Xiangya Hospital of Central South University

Recruiting

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

Hepatocellular Carcinoma

China
Qidong Gaitianli Medicines Co., Ltd
Huazhong University of Science and Technology

Terminated

Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy

Hepatic Carcinoma

China
Mauna Kea Technologies

Unknown

Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery (PERSEE)

Hepatocarcinoma | Hepatic Tumor | Hepatic Metastasis

France
Stefano Colagrande
University of Trieste; University of Rome Tor Vergata; Azienda Socio Sanitaria... and other collaborators

Completed

Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

Liver Metastases | Hepatocarcinoma

Italy
Fudan University

Recruiting

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

Hepatocarcinoma

China
Yue Han

Recruiting

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Hepatocarcinoma

China
Humanitas Clinical and Research Center

Completed

Study on the Quality of Life (QoL) After Liver Surgery

Quality of Life | Cholangiocarcinoma | Hepatocarcinoma

Italy
University of Milano Bicocca

Not yet recruiting

Hepatocarcinoma Recurrence on the Liver Study - Part2 (HERCOLES2)

Cirrhosis | Surgery | Liver Cancer | Recurrence Tumor

Italy
Assistance Publique - Hôpitaux de Paris

Recruiting

METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors (PROMETHEP)

Hepatocarcinoma | Pancreatic Tumor

France
Azienda Ospedaliera Universitaria Mater Domini,...
Associazione Italiana per la Ricerca sul Cancro

Completed

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment (LNA-i-miR221)

Advanced Solid Tumor | Hepatocarcinoma | Multiple Myeloma, Refractory

Italy
Peking Union Medical College Hospital

Not yet recruiting

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Liver Transplant; Complications | Recurrent Osteosarcoma | Hepatocarcinoma | High-Risk Cancer

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Melanoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Pancreas Cancer | Colo-rectal Cancer | Renal Cancer | Hepatocarcinoma

China
Centro di Riferimento Oncologico - Aviano

Recruiting

A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) (POPCORN)

Melanoma | Cervical Cancer | Breast Cancer | Gastric Cancer | Pancreatic Cancer | Ovarian Cancer | Solid Tumor | Bile Duct Cancer | Advanced Solid Tumor | Endometrial Cancer | Hepatocarcinoma | Locally Advanced Solid Tumor | Colon Rectal Cancer | Vulva Cancer

Italy

Clinical Trials on Hepatocarcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations